Who owns RESHAPE LIFESCIENCES INC?
- Ticker: RSLS
- CUSIP Number: 76090r200
Tip: Access positions for across all investors
Analyze quarterly positions in Reshape Lifesciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Reshape Lifesciences stock
Who bought or sold RESHAPE LIFESCIENCES INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Vanguard Group | 50k | $9.2k | 0% | Mar 2024 |
|
Tower Research Capital | 50k | $9.1k | 1341% | Mar 2024 |
|
BlackRock | 34k | $6.3k | 0% | Mar 2024 |
|
Millennium Management | 30k | $5.5k | 41% | Mar 2024 |
|
Goldman Sachs Group | 23k | $4.2k | 100% | Mar 2024 |
|
Jane Street | 23k | $4.2k | 100% | Mar 2024 |
|
Geode Capital Management | 18k | $3.4k | 0% | Mar 2024 |
|
Two Sigma Securities | 13k | $2.4k | -83% | Mar 2024 |
|
XTX Topco | 12k | $2.3k | 100% | Mar 2024 |
|
Qube Research & Technologies | 400.00 | $74.000000 | 100% | Mar 2024 |
|
Wells Fargo & Company | 183.00 | $34.001400 | 81% | Mar 2024 |
|
Cornerstone Planning Group | 135.00 | $23.004000 | 100% | Mar 2024 |
|
Advisor Group Holdings | 5.00 | $0 | 0% | Mar 2024 |
|
Group One Trading | 3.00 | $0.999900 | 0% | Mar 2024 |
|
UBS Group | 2.00 | $0 | 0% | Mar 2024 |
|
Jpmorgan Chase & Co | 1.00 | $0 | 100% | Mar 2024 |
|
Atlantic Trust | 1.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Reshape Lifesciences?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Armistice Capital | Sep 2023 | 188k | $64k |
Virtu Financial | Dec 2023 | 74k | $18k |
Citadel Advisors | Dec 2023 | 73k | $18k |
Morgan Stanley | Sep 2023 | 1.00 | $0 |